Atom Investors LP Erasca, Inc. Put Options Transaction History
Atom Investors LP
- $1.07 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ERAS
# of Institutions
149Shares Held
216MCall Options Held
258KPut Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA22.7MShares$35.5 Million1.52% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD20.3MShares$31.7 Million0.02% of portfolio
-
Vr Adviser, LLC New York, NY17.9MShares$27.9 Million4.49% of portfolio
-
Logos Global Management LP San Francisco, CA15MShares$23.4 Million2.46% of portfolio
-
Suvretta Capital Management, LLC New York, NY14.5MShares$22.6 Million0.63% of portfolio
About Erasca, Inc.
- Ticker ERAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 122,147,000
- Market Cap $191M
- Description
- Erasca, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. The company's lead candidates include ERAS-007, an oral inhibitor of ERK1/2 for the treatment of non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; ...